🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseNon-invasive MASH biomarkers — March 2026 Page 8

Non-invasive MASH biomarkers — March 2026

AttorneyGrant Thu, Feb 8, 2024 at 1:03 AM 54 replies 3,138 viewsPage 8 of 11
SaraMom3
Member
456
2,345
Aug 2024
Ohio
Aug 23, 2024 at 11:07 PM#36
labquiet_amy said:
If you are going to change something, change one thing and give it long enough to express itself.

That is right, and it stops being right at the edges. The general case is well behaved; the interesting cases in this thread are all at the boundary where the general case breaks.

Last edited: Aug 24, 2024 at 3:07 AM
9 7BethLabQueen, ChrisMacros, KetoKyle and 6 others
Reply Quote Save Share Report
pete_nash
Member
312
1,345
Aug 2024
Nashville, TN
Sep 4, 2024 at 4:43 AM#37
labquiet_amy said:
If you are going to change something, change one thing and give it long enough to express itself.

Genuinely useful, thank you. I had the facts and not the framework. I will report back once I have actually tried it.

10 8Dr.Martinez, mike_mod, SarahChen_PharmD and 7 others
Reply Quote Save Share Report
hyun_seoul
Member
345
1,456
Jul 2024
Seoul, KR
Sep 15, 2024 at 10:12 AM#38

From the other side of the consultation, briefly. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

Ask again with the specifics and you will get a better answer than this one.

11 9MASHdoc_SA, GenomicsKate, Dr.ObesityMed and 8 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.MetabolicMD
VIP Member
2,345
16,789
Jan 2024
Rochester, MN
Sep 26, 2024 at 3:35 PM#39
hyun_seoul said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

This is my experience too, for whatever a second data point is worth. Nothing to add that would improve it.

Last edited: Sep 26, 2024 at 5:35 PM
12 10Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 9 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Oct 7, 2024 at 8:51 PM#40
hyun_seoul said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

There is a second half to this that has not been said yet. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

34 7amy_econ_NJ, bbq_ray_KC, oliver_london and 31 others
Reply Quote Save Share Report

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register